Associated Papers
New mutations and new phenotypes: a case of Major Histocompatibility Complex Class II Deficiency.
Li X et al.
Immunologic Research, 2024
Clinical, Immunological, and Genetic Findings in Iranian Patients with MHC-II Deficiency: Confirmation of c.162delG RFXANK Founder Mutation in the Iranian Population.
Mousavi Khorshidi MS et al.
Journal of Clinical Immunology, 2023
Sequence and Structure-Based Analyses of Human Ankyrin Repeats.
Chakrabarty B et al.
Molecules (basel, Switzerland), 2022
35056738 (PubMed )
Supplement: molecules-27-00423-s001.zip › SupplementaryFileS4.xlsx › Sheet1
A Novel RFXANK Mutation in a Chinese Child With MHC II Deficiency: Case Report and Literature Review.
Cai YQ et al.
Open Forum Infectious Diseases, 2020
Evolutionary conservation and characterization of the bare lymphocyte syndrome transcription factor RFX-B and its paralogue ANKRA2.
Long AB et al.
Immunogenetics, 2005
The ankyrin repeat as molecular architecture for protein recognition.
Mosavi LK et al.
Protein Science : a Publication of the Protein Society, 2004
Novel mutations in the RFXANK gene: RFX complex containing in-vitro-generated RFXANK mutant binds the promoter without transactivating MHC II.
Wiszniewski W et al.
Immunogenetics, 2003
Select a paper to view details